MSc. Amaylid Arteaga García, director of the National Center for Clinical Trials Coordination. Photo: Roberto Garaycoa / Cubadebate.
–
The MSc. Amaylid Arteaga García, director of the National Center for Clinical Trials Coordination, assesses the quality of Phase III of the vaccination candidates Soberana 02 and Abdala that are advancing in Havana, Santiago de Cuba, Granma and Guantánamo.
Listen here
– .
